The global biotechnology sector is undergoing a profound structural transformation, driven by the rapid convergence of artificial intelligence, high-throughput genomics,…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience an unprecedented wave of innovation, marked by significant strides in laboratory reagents, cardiovascular…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience rapid advancements across multiple disciplines, ranging from fundamental laboratory tools to advanced artificial…
Read More
Novo Nordisk Expands Cardiometabolic Portfolio With $2.3bn Hengrui Licensing Deal for Once-Weekly Oral GLP-1/GIP Agonist HRS-1596
In a strategic move to cement its leadership in the booming cardiometabolic therapeutics market, Danish pharmaceutical titan Novo Nordisk has…
Read More
FDA Approves Eli Lilly’s Once-Weekly Basal Insulin Onswik for Type 2 Diabetes Following Robust Phase III Clinical Trials
The United States Food and Drug Administration has officially granted marketing authorization to Eli Lilly and Company for Onswik, chemically…
Read More
Advancements in Multiplex Immunofluorescence, Metabolomics, and AI Integration Highlight Latest Biotech Bi-Weekly Review
The latest edition of the biotechnology bi-weekly industry review highlights a series of significant developments reshaping life sciences, focusing heavily…
Read More
Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials
Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…
Read More
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-ups
The biotech sector continues its rapid evolution, marked this week by advancements poised to streamline laboratory processes, democratize powerful AI…
Read More
The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
The past two weeks have witnessed a significant acceleration in the biopharmaceutical landscape, marked by a flurry of strategic partnerships…
Read More
Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
